Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

10.87
-0.1600-1.45%
Post-market: 10.80-0.0700-0.64%19:17 EST
Volume:3.98M
Turnover:44.09M
Market Cap:1.44B
PE:-1.43
High:11.60
Open:11.08
Low:10.72
Close:11.03
52wk High:44.28
52wk Low:7.48
Shares:132.64M
Float Shares:112.00M
Volume Ratio:1.61
T/O Rate:3.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5868
EPS(LYR):-9.2774
ROE:-522.08%
ROA:-106.25%
PB:-84.02
PE(LYR):-1.17

Loading ...

Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 07, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Major Issues Report

8-K - Current report
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2021

Major Issues Report

8-K/A [Amend] - Current report